In this section of the General Tradeshow News Site, you'll find event-related news releases from PR Newswire. The releases are listed in chronological order and are archived by month and year.
Integrates 64 Gbaud Coherent Driver Modulator With a 64 Gbaud Coherent Receiver In a Compact Package for 400ZR Pluggable Modules and Compact Daughter Cards
Silicon Valley-based Global Healthcare IT Company and Houston-based Clinical Natural Language Processing to Collaborate on AI, Medical Data and Health Informatics
VPS' Intelligent Control of Energy (ICE) technology Fuels CUI's ICE Block to Deliver the Industry's First Software Defined Power Enabled Lithium-Ion Battery Appliance
Company demonstrates FPGA industry-first 112G PAM4 transceiver technology, planned for 7nm products, and announces 58G PAM4 FPGA additions to Virtex UltraScale+ family
ViaSat-2 Demonstration Showcased Reach, Readiness and Resiliency of Viasat's Next-Gen SATCOM Network for Greater Operational Capabilities Required at the Battlespace's Tactical Edge
Industry's only event dedicated to applying Postgres to digital business challenges opens call for papers to widen conversation among practitioners and business leaders
Latest Project from IMAX® Original Film Fund Documents the Inspiring Adventures of Heroic Dogs; To Debut Exclusively in IMAX® Theatres Starting Spring 2019
The Lancet publishes findings from groundbreaking 12-week Phase 2 study of NGM282 in non-alcoholic steatohepatitis (NASH) patients employing non-invasive measures of disease activity
- ODYSSEY OUTCOMES trial met its primary endpoint, demonstrating that high-risk patients who added Praluent® (alirocumab) Injection to maximally-tolerated statins experienced significantly fewer major adverse cardiovascular events compared to those on maximally-tolerated statins alone
Research Presented at American College of Cardiology's 67th Annual Scientific Session Reveals More Than 110,000 Cardiovascular Events a Year Could Occur in High-Risk Patients With Cardiovascular Disease who are Rejected Access
- Data includes sub-analyses from RE-VERSE AD™ and RE-DUAL PCI™ trials, published in the New England Journal of Medicine in 2017, and the RE-COVERY DVT/PE™ trial
Tom Moriarty, Chief Policy and External Affairs Officer, discusses programs that help consumers manage out-of-pocket drug costs and provide cost transparency across all points of care
Olivier Blanchard, Dick Cheney, Mohamed El-Erian, Stanley Fischer, Sallie Krawcheck, Leon Panetta and Tali Sharot Among the Featured Speakers at Leading Alternative Investment Industry Gathering
Episource's newest innovations in delivering health assessments and closing all member gaps make it the premier full-service Risk Adjustment and Quality Vendor for Medicare, Commercial and Medicaid plans
New NurturMe Ancient Grain Cookies, Power Blends, and Dairy-Free Yogurt Alternatives Appeal to Health-Conscious Families; Products Begin Shipping in March
Revel CEO Jeff Fritz and Peter Eliason, Director of Analytics & Data Science, to lead roundtable on AI and health engagement at premier healthcare industry event